Cafergot Renal Contraindications
Cafergot (ergotamine tartrate + caffeine) should be used with extreme caution in patients with renal failure and is relatively contraindicated in this population due to risk of ergot toxicity and vasospastic ischemia. 1, 2
Specific Renal Contraindications
Dihydroergotamine (DHE), a related ergot derivative, explicitly lists renal impairment as a contraindication. 1 While the evidence provided does not specify an exact eGFR cutoff for Cafergot itself, the guideline data for DHE suggests that ergot alkaloids as a class should be avoided in patients with compromised renal function.
Key Contraindications for Ergot Derivatives:
- Renal impairment is listed as a contraindication for dihydroergotamine 1
- Renal failure is specifically mentioned as requiring extreme caution with Cafergot 2
- Patients with peripheral vascular disease should avoid Cafergot due to vasoconstrictive effects 2
Mechanism of Concern in Renal Impairment
Ergotamine causes vasoconstriction through alpha-adrenergic agonism and interactions with prostaglandins, calcium, and serotonin, affecting both arteries and veins. 2 In patients with renal impairment:
- Reduced drug clearance leads to accumulation and increased risk of ergot toxicity 3
- Elimination occurs primarily through hepatic metabolism and biliary excretion, but renal dysfunction can still impair overall clearance 3
- Vasoconstrictive effects may be exacerbated in patients with compromised renal perfusion 2
Clinical Manifestations of Ergot Toxicity
Iatrogenic ergotism can progress to fulminant necrosis and gangrene, presenting with peripheral vascular insufficiency symptoms. 2 Early warning signs include:
- Headache, nausea, vomiting, and general malaise 4
- Coldness and paresthesias of extremities 3
- Muscle pains and weakness 3
- Arterial spasm with typical angiographic patterns 2
Dosing Limitations (When Use Cannot Be Avoided)
Maximum dosing must be strictly limited to prevent toxicity: no more than 6 tablets per attack, 10 tablets per week, or 10mg ergotamine per week. 1, 3 Standard dosing for Cafergot:
- Initial dose: 2 tablets (100mg caffeine/1mg ergotamine each) at onset 1
- Subsequent doses: 1 tablet every 30 minutes 1
- Maximum per attack: 6 tablets 1
- Maximum per week: 10 tablets 1
Safer Alternatives for Migraine in Renal Impairment
Triptans are preferred over ergot derivatives for most patients and do not carry the same renal contraindications. 1 Specific options include:
- Sumatriptan: Available in subcutaneous, intranasal, and oral forms; no renal dose adjustment required 1
- Naratriptan: Longest half-life among triptans, may reduce recurrence 1
- Rizatriptan: Available as absorbable wafer (Maxalt MLT) for patients with nausea 1
Critical Monitoring and Management
If ergotamine toxicity occurs, immediate discontinuation is mandatory along with cessation of cigarette smoking and caffeine. 2 Treatment approach:
- Mild cases: Discontinuation alone may suffice 2
- Acute severe insufficiency: Nitroprusside is the drug of choice 2
- Less urgent situations: Prazosin has been effective 2
- Mechanical intervention: Intra-arterial balloon dilatation may be helpful 2
Common Pitfalls to Avoid
- Do not use Cafergot in combination with triptans - this is an absolute contraindication due to additive vasoconstrictive effects 1
- Do not exceed weekly dosing limits - ergotamine dependence and rebound headaches are common with overuse 3, 4
- Do not ignore early toxic symptoms - headache, nausea, and malaise may indicate impending serious toxicity 4
- Do not use in patients already on beta blockers, antihypertensives, or SSRIs when considering DHE, as interactions increase risk 1